Titan Medical Inc. announced that the Company has entered into a licensing agreement with Auris Health, Inc. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan?s IP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | 0.00% | 0.00% | -31.25% |
13/05 | Titan Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/04 | Titan Medical Provides Update on Merger with Conavi | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.25% | 46.11L | |
+12.85% | 23TCr | |
+13.88% | 20TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.67% | 6.49TCr | |
+18.24% | 5.43TCr | |
+7.04% | 5.21TCr | |
+10.83% | 4.52TCr | |
+5.94% | 3.74TCr |
- Stock Market
- Equities
- TMD Stock
- News Titan Medical Inc.
- Titan Medical Signs License Agreement with Auris Health, Inc